You're reading the free version. Trader adds the live tape and alerts.
Start tracking
SPRY Sale Disclosure
Fitzpatrick Alexander A · SEC Form 4 · Filed Jun 12, 2026
Sale
Calculated transaction value
$33.55K
Fitzpatrick Alexander A Chief Legal Officer
SPRY
ARS Pharmaceuticals
SPRY
Transaction date
Jun 12, 2026
Public filing date
Jun 12, 2026
Filing lag
Filed same day
SPRY daily price context
Close on/before transaction
$9.76
Jun 12, 2026
First close after public filing
$9.81
Jun 15, 2026
30-day return after filing
-21.1%
Through Jul 13, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,355 shares @ $10
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001398595-26-000004
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$33.55K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Ars Pharmaceuticals, Inc. SPRY Current | Sale | Jun 12, 2026 | $33.55K |